A Prospective Study of the Oral Manifestations of Crohn s Disease

Size: px
Start display at page:

Download "A Prospective Study of the Oral Manifestations of Crohn s Disease"

Transcription

1 CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3: A Prospective Study of the Oral Manifestations of Crohn s Disease SINEAD HARTY,* PADRAIG FLEMING, MARION ROWLAND,* ELLEN CRUSHELL,* MICHAEL MCDERMOTT,* BRENDAN DRUMM,* and BILLY BOURKE* *Children s Research Centre, Our Lady s Hospital for Sick Children, Department of Paediatrics, Conway Institute for Biomolecular and Biomedical Research and Dublin Molecular Medicine Center, University College Dublin, Dublin; and Dublin Dental Hospital, Trinity College Dublin, Dublin, Ireland Background & Aims: Recent studies suggest that the mouth may be involved frequently in patients with Crohn s disease (CD). The aim of this study was to document prospectively the proportion of children with oral lesions at diagnosis of CD, to describe the type of lesions found, and to examine the ability of gastroenterologists to identify correctly oral Crohn s manifestations. Methods: In a prospective 3-year study, systematic dental examinations were performed on all children with suspected inflammatory bowel disease. Each child underwent upper endoscopy, colonoscopy, and barium follow-through radiography. Results: Forty-eight of 49 children with CD were examined by the dentist. Oral CD was found in 20 patients (41.7%). Oral findings included mucogingivitis (12 patients), mucosal tags (4 patients), deep ulceration (4 patients), cobblestoning (3 patients), lip swelling (3 patients), and pyostomatitis vegetans (1 patient). Noncaseating granulomas were found in all 8 oral biopsy specimens from oral CD lesions (100%). Two patients with granulomas in oral biopsy specimens had no granulomas found in any other biopsy specimens. The presence of oral manifestations was associated with perianal disease. In only 9 patients (45%) with oral CD was the mouth found to be abnormal by the consultant gastroenterologists. Only nonspecific oral changes were seen in children with ulcerative colitis and indeterminate colitis. Conclusions: More than one third of all children presenting with CD had involvement of the mouth. The ability of physicians to recognize oral lesions was poor. Expert dental evaluation may be useful during the investigation of patients with suspected inflammatory bowel disease. Although it is recognized widely that Crohn s disease (CD) can affect any site in the gastrointestinal tract from the mouth to the anus, the recognition of oral lesions in patients with CD and their potential clinical relevance has evolved only recently. 1,2 Patients with CD often suffer from aphthous ulceration of the oral cavity. However, because these ulcers also occur commonly in patients with ulcerative colitis and in the general population, they are not specific for CD. 3 In contrast, a number of characteristic oral lesions have been described in patients with CD. These include swelling of the lips, buccal mucosal swelling or cobblestoning, deep linear ulceration, mucosal tags, and mucogingivitis The prevalence of oral lesions in CD has varied widely in previous studies. 8,13,14 In a recent retrospective study performed at our centre 8 we found a particularly high prevalence of disease-specific oral lesions in children with CD. In that study of 25 children who had been examined by a pediatric dental surgeon at the time of initial presentation, 48% had disease-specific oral lesions. In addition, granulomas were found in 75% of 8 oral biopsy specimens in that study, suggesting that the mouth may provide an important site for obtaining diagnostic tissue in children with symptoms of inflammatory bowel disease (IBD). 8 Therefore, the aim of the present study was to document prospectively the proportion of children with evidence of oral CD at initial evaluation for suspected IBD and to describe the spectrum of lesions found. We also explored whether the presence of oral lesions correlated with markers of disease severity at diagnosis, and if oral CD was associated with a particular distribution of disease elsewhere in the gastrointestinal tract. In addition, we compared the results of oral examination by consultant gastroenterologists in the clinic setting with formal oral examination by a pediatric dental surgeon. Methods Over a 3-year period between January 1999 and December 2001 we prospectively recorded the oral manifestations in children presenting with suspected CD to the gastroenterology department of Our Lady s Hospital for Sick Children. Abbreviations used in this paper: CD, Crohn s disease; CI, confidence interval; IBD, inflammatory bowel disease by the American Gastroenterological Association /05/$30.00 PII: /S (05)

2 September 2005 ORAL MANIFESTATIONS OF CD 887 More than 75% of Irish children and adolescents with pediatric IBD undergo diagnostic evaluation at our institution (Irish Paediatric Surveillance unit data , unpublished data). Information was recorded prospectively on each patient before endoscopy including age, sex, presenting symptoms, oral symptoms, family history, and medications. Clinical examination was performed on each patient and findings including weight and height were recorded. Perianal findings were noted. Blood samples were taken for full blood count and liver function including albumin and C-reactive protein levels. Small-bowel contrast studies were performed routinely after the initial assessment. The oral cavity was inspected thoroughly by 1 of the 2 consultant gastroenterologists performing the endoscopy before examination by the dentist and the findings were documented. For this study, all oral examinations were performed by the same pediatric dental surgeon (P.F.). Dental examinations were performed in a dental chair with the use of standard lighting. Systematic assessment of the submandibular lymph nodes, lips, labial mucosa and sulci, commissures, buccal mucosa and sulci, gingiva, tongue, floor of mouth, and hard and soft palate were performed and findings were recorded. Oral biopsy specimens were taken only when clinically indicated. For example, when a diagnosis of CD was clear from other findings (eg, perianal disease), an oral biopsy examination was not performed. All children underwent upper gastrointestinal endoscopy as well as colonoscopy. Biopsy specimens were taken from grossly affected tissue and from unaffected gastric and colonic mucosa. All biopsy specimens were formalin fixed and paraffin embedded. Serial H&E-stained 4- m sections were examined in each case. This typically represented 18 to 20 sections per biopsy specimen. When granulomas were found, periodic acid-schiff, Grocott, and Ziehl Neelsen stains were performed on the specimens to rule out fungal and mycobacterial disease. Data were analyzed using Epi Info (CDC, Atlanta, GA). Comparison between groups was made using odds ratios and 95% confidence intervals (CIs) for categoric variables and t tests for continuous variables. Statistical significance was set at the 5% level. Results Over the 3-year period, 80 patients were diagnosed with IBD. Final diagnoses were CD in 49 (61.3%) patients, ulcerative colitis in 22 (27.5%) patients, and indeterminate colitis in 9 (11.3%) patients. Occurrence of Oral Crohn s Disease Forty-eight of the 49 patients with CD were examined by the dentist. Findings typical of oral CD were found in 20 patients (41.7%). Nonspecific gingivitis (ie, gingival inflammation related to the presence of dental plaque) was found in 8 (16.7%) patients, and 20 (41.7%) patients had a normal oral examination. Of the 20 patients with oral CD changes, 12 were boys and 8 were girls (1.5:1) compared with 13 boys and 15 girls in children not found to have oral CD (.86:1; P not significant). The mean age for all children with CD was years (SD, 2.7 y; range, y). The mean age of children with oral CD was 11.4 years (SD, 2.5 y) and without oral CD was 12.3 years (SD, 2.8 y; P not significant). No patient was being treated specifically for oral lesions. Patients with oral CD were significantly more likely to complain of oral symptoms (odds ratio, 4.9; 95% CI, ; P.01) and most complained of more than 1 symptom (mouth ulcers in 11 patients, angular stomatitis in 5 patients, and cheek/lip swelling in 8 patients). However, there was no difference in the duration of oral symptoms between the groups (mean difference, 2.9 mo; 95% CI, 4.7 to 10.5). The duration of oral symptoms ranged from 1 to 56 months (mean, 4.9 mo; SD, 12.7 mo). Oral symptoms did not precede systemic symptoms in any of the patients with oral CD. Manifestations of Oral Crohn s Disease More than half the patients (n 11) had more than 1 type of oral lesion (Figure 1). The most common oral finding was mucogingivitis (n 12), followed by mucosal tags (n 4), deep ulceration (n 4), cobblestoning (n 3), and lip swelling (n 3). One patient had pyostomatitis vegetans. Oral biopsy examinations were performed on 8 patients with oral CD. Noncaseating granulomas were found in biopsy material from all 8 patients (100%) undergoing oral biopsy examination. Five patients had biopsy specimens taken from areas of mucogingivitis, 1 patient from a tag, 1 patient from an area of cobblestoning, and 1 patient from an ulcer. Most of the oral biopsy specimens were taken from the buccal mucosa. Two patients with granulomas in oral biopsy specimens did not have granulomas present in multiple biopsy specimens taken from the upper and lower gastrointestinal tract. Clinical and Laboratory Features Associated With Oral Crohn s Disease There was no difference in the frequency of intestinal and systemic symptoms (Table 1) or the severity of laboratory markers (Table 2) between the 2 groups. The site of intestinal CD was compared in those with and without oral CD. Five children were infected with Helicobacter pylori. The presence or absence of Crohn s gastritis, as opposed to H pylori gastritis, could not be

3 888 HARTY ET AL CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Vol. 3, No. 9 Figure 1. (A) Lip swelling with fissures. (B) Cobblestone appearance of the buccal mucosa. (C) Linear ulceration deep in the mandibular vestibule. (D) Mucosal tag on the buccal aspect of the gingiva. (E) Mucogingivitis in relation to the maxillary permanent incisors. distinguished reliably in these patients and, therefore, they were excluded from this analysis. Among the remaining 43 children, those with oral CD were significantly more likely to have perianal disease than those without oral CD (10 of 20 [50%] compared with 4 of 23 [14%]; P.023, based on univariate analysis). However, other sites of disease were affected similarly in both groups (Table 3). Ability of Physicians to Recognize Oral Crohn s Disease Forty-six children with CD had oral findings recorded by both the pediatric gastroenterologist and the dentist. Agreement between the dentist and gastroenterologist was poor (,.22; 95% CI,.06 to.50). In 8 children without oral CD the gastroenter-

4 September 2005 ORAL MANIFESTATIONS OF CD 889 Table 1. Comparison of Intestinal and Systemic Manifestations Among Patients With and Without Oral CD Oral CD (total 20) Nonoral CD (total 28) Symptoms n % n % Odds ratio 95% CI P Loss of appetite NS Oral symptoms Mouth ulcers NS Angular stomatitis NS Cheek swelling a Vomiting NS Epigastric pain 0 0 a 1 4 Abdominal pain NS Tenesmus NS Blood per rectum NS Constipation NS Malena 0 0 a 0 0 Perirectal disease NS Arthritis 0 0 a 2 7 Clubbing NS Erythema nodosum NS Uveitis 0 0 a 0 0 NS, not significant. a No calculations were performed for cells with zero values. ologist classified the mouth as abnormal, and in 11 (55%) children with oral CD the gastroenterologist failed to identify the oral CD lesions correctly. The presence of mucogingivitis appeared to be particularly difficult for the nonoral expert to appreciate with only 4 of 12 cases correctly identified. Oral Findings in Children With Ulcerative Colitis and Indeterminate Colitis Although this study aimed to document the occurrence of oral findings in CD, a substantial proportion of children ultimately diagnosed with ulcerative colitis or indeterminate colitis also were examined. Of 22 patients diagnosed with ulcerative colitis during the study period, a dental examination was performed in 15 (68.2%). Only 2 patients had abnormal oral findings, comprising nonspecific gingivitis related to periodontal disease in both. Of these children 1 underwent oral biopsy examination that revealed the presence of acute and chronic inflammation without granulomas. Similarly, 7 of 9 patients with indeterminate colitis were examined by the dentist. Two patients were found to have nonspecific gingivitis; 1 patient underwent oral biopsy examination that revealed the presence of acute and chronic inflammation without granulomas. Discussion In this prospective study we confirmed that children with CD commonly harbor disease-specific oral Table 2. Comparison of Clinical and Laboratory Data for Patients With and Without Oral CD Laboratory value Oral CD, N 20 (SD) Nonoral CD, N 28 Mean difference 95% CI of mean difference Hemoglobin 99.9 (34.6) (15.6) to 6.1 Hematocrit 30.6 (11.5) 32.3 (7.8) to 3.9 MCH 21.1 (8.1) 24.3 (2.8) to.17 MCV 69.9 (17.4) 75.3 (6.4) to 1.8 Albumin 32.6 (5.3) 34.4 (6.4) to 1.8 ESR 37.1 (20.9) n (18.4) n to 16.5 CRP 39.2 (35.1) n (25.5) n to 29.8 Platelets (233.8) (136.5) to Duration of symptoms 12.7 (17.7) 9.7 (8.1) to Duration of oral symptoms 4.2 (12.6) 1.1 (5.1) to 8.44 NOTE. The use of ESR was replaced by CRP at our institution. MCH, mean cell hemoglobin; MCV, mean cell volume; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.

5 890 HARTY ET AL CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Vol. 3, No. 9 Table 3. Disease Location: Comparison of Site of Disease in Children With and Without Oral Lesions Using Single Group Comparisons Site of disease Oral CD (total 20) Nonoral CD (total 23) n % n % Odds ratio 95% CI P Stomach NS Small bowel NS Ileum NS Colon NS Perianal NS, not significant. manifestations at the time of diagnosis. At more than 40% the occurrence of oral CD correlates well with the findings of a previous retrospective study at our institution. 8 In that study, 48% of 25 children had oral involvement at the time of diagnosis of CD. The slightly lower proportion of children with oral CD in the present cohort likely is accounted for by selection bias inherent in the retrospective design of our previous investigation. However, taken together, these studies clearly indicate that the oral cavity is a useful source of diagnostic material in children presenting with IBD. Previously 8 we have speculated as to the reasons underlying the relatively higher prevalence of oral CD in our population compared with other studies. 4,5,13,14 Factors such as possible increased involvement of the proximal gastrointestinal tract in younger patients 15 and examination at the time of diagnosis, before the institution of drug therapy, may have increased the relative numbers of children with oral CD in our population. However, routine examination of the oral cavity by an experienced dental surgeon was perhaps the major factor underlying the high prevalence of oral CD findings in the present study. Although our pediatric gastroenterology group have an established interest in oral CD, the ability of the physicians in this study to identify and classify accurately the oral CD findings was poor (,.22; 95% CI,.06 to.50). Clearly, to be useful, oral examination in patients with IBD requires involvement of an experienced dentist or oral physician. The potential usefulness of oral CD findings as a source of diagnostic material in patients with CD is underscored by the frequency with which granulomas are identified in these lesions. In the present study we could not justify on ethical grounds a routine oral biopsy examination, especially in children in whom the diagnosis of CD was in little doubt (eg, those with perianal disease at presentation). However, when oral biopsy examination was performed granulomas were identified in all 8 lesions pre-identified as those of oral CD. In contrast, the 2 biopsy specimens from patients with ulcerative and indeterminate colitis harbored nonspecific inflammatory changes without the presence of granulomas. The type of mouth lesions identified in the present study covered the spectrum of oral CD manifestations In our previous study 8 mucosal tags and labial swelling were the most common oral CD findings. However, in the present study mucogingivitis (Figure 1E) was the single most common manifestation. This lesion is particularly difficult for physicians without oral expertise to identify accurately. When a biopsy examination was performed we found areas of mucogingivitis to harbor granulomas commonly, findings that simultaneously support the contention that these particular lesions are genuine disease-specific manifestations of CD and also emphasize their potential contribution toward establishing a diagnosis of CD in an individual patient. Previous studies have pointed to an apparent association between ileocolonic disease and oral CD, 2 4 and in our original retrospective cohort 8 we found that inflammation of the proximal gastrointestinal tract was more common in children with oral CD. However, in the present study, apart from an increased prevalence of oral CD in those with perianal disease, we could not show that those with oral manifestations differed phenotypically from children without oral CD. It is noteworthy that in the present study histologic evidence of inflammation was found very commonly in the stomachs of children with CD, regardless of the presence or absence of oral changes (Table 3). This finding is in keeping with data from a previous retrospective study we published that showed a very high prevalence of inflammation in the gastric mucosa of children with IBD. 16 It has been suggested that oral CD is a Celtic disease 17 and it is possible that the apparent variation in prevalence of oral CD reflects ethnic differences in susceptibility to this extraintestinal manifestation of IBD. In this respect a recent genetic study of Irish and Scottish patients with CD suggests that NOD2/CARD 15 muta-

6 September 2005 ORAL MANIFESTATIONS OF CD 891 tions may be less prevalent than in other Caucasian populations. 18 It would be of interest to characterize NOD2/CARD 15 mutations in patients with oral CD to ascertain if they differ genotypically from those without oral involvement. In summary, we have found that oral manifestations of CD are common in children presenting with IBD and are difficult to discern by gastroenterologists in a conventional clinical setting. These lesions commonly contain granulomas and are accessible easily for diagnostic biopsy examination. Oral examination by an experienced dental surgeon or oral physician can be an important adjunct to the investigation of patients with suspected IBD. References 1. Dudeney TP, Todd IP. Crohn s disease of the mouth. Proc R Soc Med 1969;62: Basu MK, Asquith P. Oral manifestations of inflammatory bowel disease. Clin Gastroenterol 1980;9: Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55: Basu M, Asquith P, Thompson RA, et al. Oral manifestations of Crohn s disease. Gut 1975;16: Halme LMJ, Laine P, VonSmitten K. Oral findings in patients with active or inactive Crohn s disease. Oral Surg Oral Med Oral Pathol 1993;76: Boraz RA. Oral manifestations of Crohn disease: update of the literature and report of case. J Dent Child 1988;55: Scully C, Cochran KM, Russell RI, et al. Crohn s disease of the mouth: an indicator of intestinal involvement. Gut 1982;23: Pittock S, Drumm B, Fleming P, et al. The oral cavity in Crohn s disease. J Pediatr 2001;138: Field AE. Oral lesions in IBD. Inflamm Bowel Dis 2001;2: Stricker T, Braegger CP. Oral manifestations of Crohn s disease. N Engl J Med 2000;342: Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn s disease. An analysis of 79 cases. J Clin Gastroenterol 1991;13: Dupuy A, Cosnes J, Revuz J, et al. Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol 1999;135: Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 1994;19: Cosnes A, Dupuy A, Revuz J, et al. Longterm evolution of oral localisation of Crohn s disease. Gastroenterology 1998;114:A Wagtmans MJ, Verspaget HW, Lamers CB, et al. Clinical aspects of Crohn s disease of the upper gastrointestinal tract: a comparison with distal Crohn s disease. Am J Gastroenterol 1997;92: Sharif F, McDermott M, Dillon M, et al. Focally enhanced gastritis in children with Crohn s disease and ulcerative colitis. Am J Gastroenterol 2002;97: Challacombe SJ. Oro-facial granulomatosis and oral Crohns disease: are they specific diseases and do they predict systemic Crohns disease? Oral Dis 1997;3: Bairead E, Harmon DL, Curtis AM, et al. Association of NOD2 with Crohn s disease in a homogenous Irish population. Eur J Hum Genet 2003;11: Address requests for reprints to: Billy Bourke, MD, Children s Research Centre, Our Lady s Hospital for Sick Children, Crumlin, Dublin 12, Ireland. Billy.Bourke@UCD.ie; fax: (353)

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel

More information

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel

More information

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.

More information

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic WHAT IS INFLAMMATORY BOWEL DISEASE (IBD)? Chronic inflammation of the intestinal tract Two related

More information

For the past 40 years, it has been standard practice to obtain

For the past 40 years, it has been standard practice to obtain ORIGINAL ARTICLE: GASTROENTEROLOGY Good Agreement Between Endoscopic Findings and Biopsy Reports Supports Limited Tissue Sampling During Pediatric Colonoscopy Michael A. Manfredi, Hongyu Jiang, Lawrence

More information

children Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae

children Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae MR enterography for Crohn s disease in children BOAZ KARMAZYN, MD PEDIATRIC RADIOLOGY ASSOCIATE PROFESSOR Characterization Crohn disease Idiopathic chronic transmural IBD Increasing incidence Age 7/100,000

More information

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Inflammatory Bowel Disease When is diarrhea not just diarrhea? Inflammatory Bowel Disease When is diarrhea not just diarrhea? Jackie Kazik, MA, PA C CME Resources CAPA Annual Conference, 2011 Inflammatory Bowel Disease Objectives Discuss what is known about the pathophysiology

More information

MELKERSSON-ROSENTHAL SYNDROME AND CROHN S DISEASE

MELKERSSON-ROSENTHAL SYNDROME AND CROHN S DISEASE British Journal of Oral Surgery (1980) 18, 254-258 @ The British Association of Oral Surgeons OOO7-117X/80/00370254$02.00 MELKERSSON-ROSENTHAL SYNDROME AND CROHN S DISEASE N. WORSAAE,~* K. C. CHRISTENSEN,2

More information

IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease

IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease Inflammatory Bowel Disease Experts in Autoimmunity Inova Diagnostics offers a complete array of methods to aid in the diagnosis

More information

Chronic Abdominal Pain in Children

Chronic Abdominal Pain in Children PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Chronic Abdominal Pain in Children. These podcasts are designed to give medical students an overview of key topics in

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: fecal_calprotectin_test 8/2009 11/2017 11/2018 11/2017 Description of Procedure or Service Fecal calprotectin

More information

W. R. TYLDESLEY, D.D.s., PH.D., F.D.S.R.C.S.

W. R. TYLDESLEY, D.D.s., PH.D., F.D.S.R.C.S. British Journal of Oral Surgery 17 (I 979~80), 1-9 ORAL CROHN S DISEASE AND RELATED CONDITIONS School W. R. TYLDESLEY, D.D.s., PH.D., F.D.S.R.C.S. of Dental Surger,y, Pembroke Place, P.O. Box 147, Liverpool,

More information

Kings College London Dental Institute. Guy s & St Thomas NHS Foundation Trust Oral Medicine Unit. Disease Activity Scoring sheets

Kings College London Dental Institute. Guy s & St Thomas NHS Foundation Trust Oral Medicine Unit. Disease Activity Scoring sheets Kings College London Dental Institute Guy s & St Thomas NHS Foundation Trust ral Medicine Unit Disease Activity Scoring sheets Clinical scoring systems for oral mucosal Diseases The routine clinical management

More information

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014 Management and Medical Therapies for Crohn disease: strategies to enhance mucosal healing Anne Griffiths MD, FRCPC SickKids Hospital, University of Toronto Buenos Aires, August 16, 2014 New onset Crohn

More information

Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics

Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics 38 Original Article Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics Anuchapreeda S Leelakusolvong S Charatcharoenwitthaya

More information

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease Management in South Africa in 2016 Pharmaceutical Care Management Association Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease

More information

What do we need for diagnosis of IBD

What do we need for diagnosis of IBD What do we need for diagnosis of IBD Kaichun Wu Dept. of Gastroenterology, Xijing Hospital Fourth Military Medical University Xi an an,, China In China UC 11.6/10 5,CD 1.4/10 5 Major cause of chronic diarrhea

More information

Research Article Endoscopic and Pathologic Changes of the Upper Gastrointestinal Tract in Crohn s Disease

Research Article Endoscopic and Pathologic Changes of the Upper Gastrointestinal Tract in Crohn s Disease BioMed Research International, Article ID 610767, 6 pages http://dx.doi.org/10.1155/2014/610767 Research Article Endoscopic and Pathologic Changes of the Upper Gastrointestinal Tract in Crohn s Disease

More information

Focally Enhanced Gastritis in Newly Diagnosed Pediatric Inflammatory Bowel Disease

Focally Enhanced Gastritis in Newly Diagnosed Pediatric Inflammatory Bowel Disease Focally Enhanced Gastritis in Newly Diagnosed Pediatric Inflammatory Bowel Disease The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

More information

The revised Porto criteria for diagnosing

The revised Porto criteria for diagnosing R E S E A R C H P A P E R Long-term Outcome of Inflammatory Bowel Disease Unclassified in Children SIBA PROSAD PAUL AND BHUPINDER KAUR SANDHU From Bristol Royal Hospital for Children, Upper Maudlin Street,

More information

World Journal of Colorectal Surgery

World Journal of Colorectal Surgery World Journal of Colorectal Surgery Volume 6, Issue 5 2016 Article 4 Isolated Jejunal Crohn s Disease, A Diagnostic Dilemma Elise Biesboer BS Lacey Stelle MD Michelle M. Olson MD, MACM Paul Tender MD University

More information

How to differentiate Segmental Colitis Associated with Diverticulosis and Inflammatory Bowel Diseases?

How to differentiate Segmental Colitis Associated with Diverticulosis and Inflammatory Bowel Diseases? How to differentiate Segmental Colitis Associated with Diverticulosis and Inflammatory Bowel Diseases? Alessandro Armuzzi Lead IBD Unit Complesso Integrato Columbus Fondazione Policlinico Gemelli Università

More information

Faecal Calprotectin. Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS)

Faecal Calprotectin. Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS) Faecal Calprotectin Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS) Reliable, Non Invasive Identification of IBD vs IBS Available from Eurofins

More information

Chromoendoscopy - Should It Be Standard of Care in IBD?

Chromoendoscopy - Should It Be Standard of Care in IBD? Chromoendoscopy - Should It Be Standard of Care in IBD? John F. Valentine, MD, FACG Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Utah What is the point of

More information

Clinical Oral Manifestation in Gastrointestinal Disorders

Clinical Oral Manifestation in Gastrointestinal Disorders LKN JOURNL OF STOMTOLOGY ISSN 1107-1141 STOMTOLOGICL SOCIETY Clinical Oral Manifestation in Gastrointestinal Disorders SUMMRY im: to evidence extraoral and intraoral, subjective and objective, symptoms

More information

RE: Title: Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis

RE: Title: Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis September 10, 2018 Professor Xue-Jiao Wang, MD Science Editor Editorial Office 'World Journal of Gastroenterology' RE: 40814 Title: Practical fecal calprotectin cut-off value for Japanese patients with

More information

How do I evaluate a patient with a swollen lip?

How do I evaluate a patient with a swollen lip? How do I evaluate a patient with a swollen lip? Yang Gu, BDS, MSc; Michele Williams, BSN, DMD, FRCD(C); Catherine F. Poh, DDS, PhD, FRCD(C) Tags: diagnosis oral pathology Cite this as: J Can Dent Assoc

More information

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology Patho Basic Chronic Inflammatory Bowel Diseases Jürg Vosbeck Pathology General Group of chronic relapsing diseases with chronic bloody or watery diarrhea Usually ulcerative colitis (UC) or Crohn s disease

More information

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003 Surgical Management of IBD Val Jefford Grand Rounds October 14, 2003 Introduction Important Features Clinical Presentation Evaluation Medical Treatment Surgical Treatment Cases Overview Introduction Two

More information

IBD. Crohn s. Outline. Ulcerative colitis versus Crohn s disease: is biopsy useful? UC vs. Crohn s? Is it easy? Biopsy settings 21/07/2017 IBD

IBD. Crohn s. Outline. Ulcerative colitis versus Crohn s disease: is biopsy useful? UC vs. Crohn s? Is it easy? Biopsy settings 21/07/2017 IBD Outline Ulcerative colitis versus Crohn s disease: is biopsy useful? Roger Feakins Colorectal biopsies Ileal and upper GI biopsies Special situations New techniques Summary Inflammatory bowel disease (IBD)

More information

Kids Like to Break the Rules: Gastrointestinal Pathology in Children

Kids Like to Break the Rules: Gastrointestinal Pathology in Children Kids Like to Break the Rules: Gastrointestinal Pathology in Children Jeffrey Goldsmith MD Director of Surgical Pathology, Beth Israel Deaconess Medical Center; Consultant in Gastrointestinal Pathology,

More information

Crohn's disease of the duodenum

Crohn's disease of the duodenum Crohn's disease of the duodenum F. WARREN NUGENT,' M. RICHMOND,2 AND S. K. PARK3 Gut, 1977, 18, 115-120 From the Department of Gastroenterology, Lahey Clinic Foundation, Boston, Massachusetts, USA SUMMARY

More information

INFLAMMATORY BOWEL DISEASE

INFLAMMATORY BOWEL DISEASE National University Faculty of Medicine INFLAMMATORY BOWEL DISEASE Gehan M. Osman, MD. MBBS Pediatrician Jaffar Ibn Auf Specialized Hospital EDUCATIONAL OBJECTIVES Definitions and spectrum of (IBD) Epidemiology

More information

Initiation of Maintenance Treatment in Moderate to Severe New Onset Crohn s Disease

Initiation of Maintenance Treatment in Moderate to Severe New Onset Crohn s Disease Initiation of Maintenance Treatment in Moderate to Severe New Onset Crohn s Disease The Case for Starting with Anti-TNFα Agents Maria Oliva-Hemker, M.D. Chief, Division of Pediatric Gastroenterology &

More information

Standard of care Inflammatory Bowel Disease (IBD)

Standard of care Inflammatory Bowel Disease (IBD) Standard of care Inflammatory Bowel Disease (IBD) Inflammatory bowel disease (IBD) Tens of thousands of Australians live with the debilitating symptoms of Crohn s disease or ulcerative colitis the two

More information

Chromoendoscopy as an Adjunct to Colonoscopy

Chromoendoscopy as an Adjunct to Colonoscopy Chromoendoscopy as an Adjunct to Colonoscopy Policy Number: 2.01.84 Last Review: 1/2018 Origination: 7/2017 Next Review: 7/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide

More information

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS SURGICAL MANAGEMENT OF ULCERATIVE COLITIS Cary B. Aarons, MD Associate Professor of Surgery Division of Colon & Rectal Surgery University of Pennsylvania AGENDA Background Diagnosis/Work-up Medical Management

More information

Diarrhea may be: Acute (short-term, usually lasting several days), which is usually related to bacterial or viral infections.

Diarrhea may be: Acute (short-term, usually lasting several days), which is usually related to bacterial or viral infections. Pediatric Gastroenterology Conditions Evaluated and Treated Having a child suffer with abdominal pain, chronic eating problems, or other gastrointestinal disorders can be a very trying time for a parent.

More information

Terumitsu; Nagayasu, Takeshi

Terumitsu; Nagayasu, Takeshi NAOSITE: Nagasaki University's Ac Title Author(s) Citation A rare case of segmental ulcerative Tominaga, Tetsuro; Nonaka, Takashi; Shuichi; Kunizaki, Masaki; Sumida, Terumitsu; Nagayasu, Takeshi Acta medica

More information

Entrustable Professional Activity

Entrustable Professional Activity Entrustable Professional Activity 1. EPA Title: Care of infants, children and adolescents with inflammatory bowel disease 2. Description of Activity Practicing subspecialists must be trained to care for

More information

Inflammatory Bowel Disease: Updates and Controversies CASE #1 CASE #1 8/6/2015. What is the most likely diagnosis?

Inflammatory Bowel Disease: Updates and Controversies CASE #1 CASE #1 8/6/2015. What is the most likely diagnosis? Inflammatory Bowel Disease: Updates and Controversies Tehttp://192.185.93.102/~paulkeij/wpcontent/uploads/2013/07/collaboration.jpgxt August 7, 2015 Meagan M Costedio, MD; Colorectal Surgery; Cleveland

More information

ABDOMINAL PAIN, CHRONIC

ABDOMINAL PAIN, CHRONIC Introduction Incidence Aetiology Clinical Assessment Formulation Investigations Management Prognosis Conclusion References Introduction The generally accepted definition of this condition is three or more

More information

Gastric atrophy: use of OLGA staging system in practice

Gastric atrophy: use of OLGA staging system in practice Gastroenterology and Hepatology From Bed to Bench. 2016 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Gastric atrophy: use of OLGA staging system in practice Mahsa

More information

Endoscopy in IBD. F.Hartmann K.Kasper-Kliniken (St.Marienkrankenhaus) Frankfurt/M.

Endoscopy in IBD. F.Hartmann K.Kasper-Kliniken (St.Marienkrankenhaus) Frankfurt/M. F.Hartmann K.Kasper-Kliniken (St.Marienkrankenhaus) Frankfurt/M. F.Hartmann@em.uni-frankfurt.de Indications for endoscopy Diagnosis Management Surveillance Diagnosis Single most valuable tool: ileocolonoscopy

More information

Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R.

Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R. UvA-DARE (Digital Academic Repository) Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R. Link to publication Citation for published version

More information

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis Screening for Colorectal Neoplasia in Inflammatory Bowel Disease Francis A. Farraye MD, MSc Clinical Director, Section of Gastroenterology Co-Director, Center for Digestive Disorders Boston Medical Center

More information

Guided by Dr. Michal Amitai Head of Abdominal Imaging Department of Diagnostic Imaging Sheba Medical Center Sackler School of Medicine, Tel Aviv

Guided by Dr. Michal Amitai Head of Abdominal Imaging Department of Diagnostic Imaging Sheba Medical Center Sackler School of Medicine, Tel Aviv Guided by Dr. Michal Amitai Head of Abdominal Imaging Department of Diagnostic Imaging Sheba Medical Center Sackler School of Medicine, Tel Aviv University 1 SHARE study My year Collaboration between gastroenterology

More information

Crohn s Disease. Resident Lecture 1/17/19

Crohn s Disease. Resident Lecture 1/17/19 Crohn s Disease Resident Lecture 1/17/19 Objectives Features/Classification of Crohn s Disease Medical Treatment Surgical Indications Surgical Considerations 2 Case 25 yo F presents to your office with

More information

PIBD03 - Page 1 of June-03

PIBD03 - Page 1 of June-03 ENROLLMENT INFO Patient Demographics [enroll01] Date of assessment [e_assessdt] 1. Patient birthdate: [birthdt] 2a. Month of diagnosis (please enter the 2-digit month) [e_diagmnth] 2b. Year of diagnosis

More information

Treating Crohn s and Colitis in the ASC

Treating Crohn s and Colitis in the ASC Treating Crohn s and Colitis in the ASC Kimberly M Persley, MD Texas Digestive Disease consultants TASC Meeting Outline IBD 101 Diagnosis Treatment Burden of Disease Role of ASC Inflammatory Bowel Disease

More information

Inflammatory Bowel Disease Ischemic bowel disease

Inflammatory Bowel Disease Ischemic bowel disease Inflammatory Bowel Disease Ischemic bowel disease Inflammatory Bowel Disease The two disorders that comprise IBD are: ulcerative colitis Crohn disease The distinction between ulcerative colitis and Crohn

More information

Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation?

Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation? Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation? Edward V. Loftus, Jr., M.D. Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic

More information

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Predicting the natural history of IBD Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Patient 1 Patient 2 Age 22 Frequent cramps and diarrhea for 6 months Weight

More information

GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint

GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Gastroenterology MOC exam blueprint Based on feedback from physicians that MOC assessments

More information

GRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM

GRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM GASTROENTEROLOGY 64: 1071-1076, 1973 Copyright 1973 by The Williams & Wilkins Co. Vol. 64, No.6 Printed in U.S.A. GRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM JAMES A. NELSON,

More information

ד"ר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה

דר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה ד"ר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה Presentaion: S.A is 38 years old. Referred for rectal bleeding investigation. Describes several occasions of bleeding and abdominal pain.

More information

PEDIATRIC INFLAMMATORY BOWEL DISEASE

PEDIATRIC INFLAMMATORY BOWEL DISEASE PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease

More information

Endpoints for Stopping Treatment in UC

Endpoints for Stopping Treatment in UC Endpoints for Stopping Treatment in UC Jana G. Hashash, MD Assistant Professor of Medicine Inflammatory Bowel Disease Center Division of Gastroenterology, Hepatology, and Nutrition University of Pittsburgh

More information

Title: Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study

Title: Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study Author's response to reviews Title: Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study Authors: Michael Manz (michael.manz@claraspital.ch) Emanuel

More information

ABDOMINAL PAIN, CHRONIC

ABDOMINAL PAIN, CHRONIC Introduction Incidence Aetiology Clinical Assessment Formulation Investigations Management Prognosis Conclusion References Introduction The generally accepted definition of this condition is three or more

More information

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES I B D m etter than this isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES What types of people have learned how to manage their IBD? Athletes Musicians Firefighters DOCTORS HEROES Artists Presidents Actors

More information

CROHN S DISEASE. The term "inflammatory bowel disease" includes Crohn's disease and the other related condition called ulcerative colitis.

CROHN S DISEASE. The term inflammatory bowel disease includes Crohn's disease and the other related condition called ulcerative colitis. CROHN S DISEASE What does it consist of? Crohn s disease is an inflammatory process that affects mostly to the intestinal tract, although it can affect any other part of the digestive apparatus from the

More information

What Every Pathologist Wants the GI Nurse to Know (and how you can help us help you)

What Every Pathologist Wants the GI Nurse to Know (and how you can help us help you) What Every Pathologist Wants the GI Nurse to Know (and how you can help us help you) Jonathan N. Glickman MD PhD Director, GI Pathology, Caris Diagnostics, Newton, MA Associate Professor of Pathology,

More information

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine Crohn's disease Crohn's disease is an inflammatory condition of the digestive tract that affects children and adults. Common features of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight

More information

A Case of Crohn s Disease with Mesalazine Allergy that was Difficult to Differentiate from Comorbid Ulcerative Colitis

A Case of Crohn s Disease with Mesalazine Allergy that was Difficult to Differentiate from Comorbid Ulcerative Colitis doi: 10.2169/internalmedicine.1607-18 http://internmed.jp CASE REPORT A Case of Crohn s Disease with Mesalazine Allergy that was Difficult to Differentiate from Comorbid Ulcerative Colitis Rumiko Tsuboi,

More information

BENEFIT APPLICATION BLUE CARD/NATIONAL ACCOUNT ISSUES

BENEFIT APPLICATION BLUE CARD/NATIONAL ACCOUNT ISSUES Medical Policy BCBSA Ref. Policy: 2.01.84 Last Review: 11/15/2018 Effective Date: 11/15/2018 Section: Medicine Related Policies 2.01.87 Confocal Laser Endomicroscopy 6.01.32 Virtual Colonoscopy/Computed

More information

Jonathan R. Dillman, MD, MSc. Associate Professor Department of Radiology Cincinnati Children s Hospital Medical Center

Jonathan R. Dillman, MD, MSc. Associate Professor Department of Radiology Cincinnati Children s Hospital Medical Center MR Enterography in Children: Interpretation & Value-Added Jonathan R. Dillman, MD, MSc Associate Professor Department of Radiology Cincinnati Children s Hospital Medical Center Disclosures Crohn s disease

More information

Ethnic Distribution of Atrophic Autoimmune Gastritis in the United States

Ethnic Distribution of Atrophic Autoimmune Gastritis in the United States Ethnic Distribution of Atrophic Autoimmune Gastritis in the United States Robert M. Genta, Regan Allen, Massimo Rugge Miraca Life Sciences Research Institute, Miraca Life Sciences, Irving, Texas UTSW University

More information

Laurie S. Conklin, M.D. Inflammatory Bowel Disease Program Children s National Medical Center

Laurie S. Conklin, M.D. Inflammatory Bowel Disease Program Children s National Medical Center Laurie S. Conklin, M.D. Inflammatory Bowel Disease Program Children s National Medical Center CROHN S DISEASE Patchy inflammation Mouth to anus involvement Full-thickness inflammation Variable involvement

More information

J Bagh College Dentistry Vol. 25(1), March 2013 Salivary assessment

J Bagh College Dentistry Vol. 25(1), March 2013 Salivary assessment Salivary assessment of Interleukin-6, C-reactive protein and albumin in ulcerative colitis patients in relation to oral findings Muhassad H. Al-Mudhaffer, B.D.S. (1) Sahar H. Abdul-Ghafoor, B.D.S., M.Sc.

More information

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center Beyond Anti TNFs: positioning of other biologics for Crohn s disease Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center Objectives: To define high and low risk patient and disease features

More information

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs. Topic Page: Crohn's disease Definition: Crohn's disease from Benders' Dictionary of Nutrition and Food Technology Chronic inflammatory disease of the bowel, commonly the terminal ileum, of unknown aetiology,

More information

Oral and neck examination for early detection of oral cancer a practical guide

Oral and neck examination for early detection of oral cancer a practical guide Oral and neck examination for early detection of oral cancer a practical guide Item type Authors Publisher Journal Article MacCarthy, Dr Denise Irish Dental Association Journal of the Irish Dental Association

More information

Dental Morphology and Vocabulary

Dental Morphology and Vocabulary Dental Morphology and Vocabulary Palate Palate Palate 1 2 Hard Palate Rugae Hard Palate Palate Palate Soft Palate Palate Palate Soft Palate 4 Palate Hard Palate Soft Palate Maxillary Arch (Maxilla) (Uppers)

More information

DIVISION OF GASTROENTEROLOGY

DIVISION OF GASTROENTEROLOGY DR. Lloyd Mayer T H E H E N R Y D. J A N O W I T Z DIVISION OF GASTROENTEROLOGY Mount Sinai is consistently ranked among the top five gastroenterology centers in the nation. The irresistible combination

More information

What is Crohn's disease?

What is Crohn's disease? What is Crohn's disease? Crohn's disease is a chronic inflammatory disorder that causes inflammation of the digestive tract. It can affect any area of the GI tract, from the mouth to the anus, but it most

More information

Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema

Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema Bahrain Medical Bulletin, Vol.24, No.3, September 2002 Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema Najeeb S Jamsheer, MD, FRCR* Neelam. Malik, MD, MNAMS** Objective: To

More information

Ulcerative Colitis. ulcerative colitis usually only affects the colon.

Ulcerative Colitis. ulcerative colitis usually only affects the colon. Ulcerative Colitis Introduction Ulcerative colitis is an inflammatory bowel disease. It is one of the 2 most common inflammatory bowel diseases. The other one is Crohn s disease. Ulcerative colitis and

More information

Bleeding in the Digestive Tract

Bleeding in the Digestive Tract Bleeding in the Digestive Tract National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH U.S. Department of Health

More information

CHEILITIS GRANULOMATOSA

CHEILITIS GRANULOMATOSA CHEILITIS GRANULOMATOSA Report of two Cases with Clinical and Diagnostic Implications Presented By Dr. Amar Sholapurkar Under the guidance of Dr.Ausaf Ahsan Department of Oral Medicine & Radiology, MCODS,

More information

6610 NE 181st Street, Suite #1, Kenmore, WA

6610 NE 181st Street, Suite #1, Kenmore, WA 660 NE 8st Street, Suite #, Kenmore, WA 9808 www.northshoredentalacademy.com.08.900 READ CHAPTER The Professional Dental Assistant (p.-9) No Key Terms Recall Questions:,,,, and 6 CLASS SYLLABUS DAY READ

More information

2015 Gastroenterology Survival Guide

2015 Gastroenterology Survival Guide 2015 Gastroenterology Survival Guide Chapter 11: ICD-9 Coding Your first line of ICD-9 coding is to attach signs or symptoms to your claim, but even after your gastroenterologist performs a diagnostic

More information

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL CROHN S DISEASE Chronic disease of uncertain etiology Etiology- genetic, environmental, and infectious Transmural

More information

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

Gastroenterology. Certification Examination Blueprint. Purpose of the exam Gastroenterology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified gastroenterologist

More information

The London Gastroenterology Partnership CROHN S DISEASE

The London Gastroenterology Partnership CROHN S DISEASE CROHN S DISEASE What is Crohn s disease? Crohn s disease is a condition, in which inflammation develops in parts of the gut leading to symptoms such as diarrhoea, abdominal pain and tiredness. The inflammation

More information

Evaluation of treatment effect in UC and CD (children)

Evaluation of treatment effect in UC and CD (children) Evaluation of treatment effect in UC and CD (children) Dr Nick Croft Digestive Diseases, Centre for Immunobiology, Blizard Institute & Barts Health NHS Trust Blizard Institute Disclosures Dr Nick Croft

More information

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 09/17/2011 Radiology Quiz of the Week # 38 Page 1 CLINICAL PRESENTATION AND RADIOLOGY

More information

Characteristics of Upper Gastrointestinal Tract Involvement in Korean Pediatric Crohn s Disease: A Multicenter Study

Characteristics of Upper Gastrointestinal Tract Involvement in Korean Pediatric Crohn s Disease: A Multicenter Study pissn: 2234-8646 eissn: 2234-8840 https://doi.org/10.5223/pghn.2017.20.4.227 Pediatr Gastroenterol Hepatol Nutr 2017 December 20(4):227-235 Original Article PGHN Characteristics of Upper Gastrointestinal

More information

Fibrotic complications of inflammatory bowel disease

Fibrotic complications of inflammatory bowel disease January 27th 2017, 8th Gastro Foundation Weekend for Fellows; Spier Hotel & Conference Centre, Stellenbosch Fibrotic complications of inflammatory bowel disease Gerhard Rogler, Department of Gastroenterology

More information

Gastric Carcinoma in Patients with Crohn Disease: Report of Four Cases

Gastric Carcinoma in Patients with Crohn Disease: Report of Four Cases 311 0361-803X/91/1 572-0311 C American Roentgen Ray Society Seth N. GIick1 Received January 1 7, 1991 ; accepted after re vision March 1 2, 1991. 1 Department of Diagnostic Radiology, Hahnemann University

More information

Policy #: 472 Latest Review Date: May 2017

Policy #: 472 Latest Review Date: May 2017 Name of Policy: Fecal Calprotectin Testing Policy #: 472 Latest Review Date: May 2017 Category: Laboratory Policy Grade: A Background/Definitions: As a general rule, benefits are payable under Blue Cross

More information

Original Article Etiologic and clinical analysis of chronic complex anal and rectal inflammation in children less than 3 years old

Original Article Etiologic and clinical analysis of chronic complex anal and rectal inflammation in children less than 3 years old Int J Clin Exp Med 2014;7(11):4016-4023 www.ijcem.com /ISSN:1940-5901/IJCEM0002461 Original Article Etiologic and clinical analysis of chronic complex anal and rectal inflammation in children less than

More information

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND Fabrizio Parente Gastrointestinal Unit, A.Manzoni Hospital, Lecco & L.Sacco School of Medicine,University of Milan - Italy

More information

A Case of Inflammatory Bowel Disease

A Case of Inflammatory Bowel Disease A Case of Inflammatory Bowel Disease Dr Barrie Rathbone www.le.ac.uk 26 year old Polish woman Admitted as emergency under surgeons RUQ and RIF pain Abdominal pain had occurred intermittently for a few

More information

Oral Signs of Systemic Diseases

Oral Signs of Systemic Diseases Oral Signs of Systemic Diseases American Academy of Dermatology San Diego, California February 17, 2018 Oral Signs of Gastrointestinal Diseases Roy S. Rogers, III, M.D. Professor of Dermatology Mayo Clinic

More information

Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease

Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease Robert Isfort, M.D. TriHealth Digestive Institute IBD Family Education Day 2019 Learning Objectives Review manifestations

More information

QJM Advance Access published January 21, 2015 BIG LIPS. M. Reveillon, V. Eble, H. Levesque, I. Marie

QJM Advance Access published January 21, 2015 BIG LIPS. M. Reveillon, V. Eble, H. Levesque, I. Marie QJM Advance Access published January 21, 2015 BIG LIPS M. Reveillon, V. Eble, H. Levesque, I. Marie Mathilde Reveillon, MD; Vincent Eble, MD; Hervé Levesque MD, PhD; Isabelle Marie, MD, PhD. Department

More information

CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD

CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD Disclosure Statement NKC: No relevant conflicts to disclose. DTR: No relevant

More information

study was undertaken to assess the epidemiology, course and outcome of UC patients attending a hospital in Jordan.

study was undertaken to assess the epidemiology, course and outcome of UC patients attending a hospital in Jordan. Ulcerative colitis (UC) is a relatively uncommon, chronic, recurrent inflammatory disease of the colon or rectal mucosa [1]. Often a lifelong illness, the condition can have a profound emotional and social

More information

Infliximab Therapy in Pediatric Patients 7 Years of Age and Younger

Infliximab Therapy in Pediatric Patients 7 Years of Age and Younger ORIGINAL ARTICLE: GASTROENTEROLOGY Infliximab Therapy in Pediatric Patients 7 Years of Age and Younger Judith R. Kelsen, Andrew B. Grossman, Helen Pauly-Hubbard, Kernika Gupta, Robert N. Baldassano, and

More information